bepotastine 1.5% preservative-free formulation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for bepotastine 1.5% preservative-free formulation, covering 2022-12-15 to 2022-12-15. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment [Phase 4]